Trial Profile
Patient Transfer Program for Transitioning From Exubera (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere Insulin (Insulin Human [rDNA Origin]) Inhalation Powder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2017
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions; Expanded access
- Sponsors MannKind Corporation
- 14 May 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Dec 2014 Planned End Date changed from 1 Jun 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov.
- 13 Dec 2013 Planned End Date changed from 1 Jan 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov.